Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer
- Resource Type
- Article
- Source
- In
Acta Pharmaceutica Sinica B December 2023 13(12):4934-4944 - Subject
- Language
- ISSN
- 2211-3835